epirubicin has been researched along with Mouth Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottschlich, S; Lippert, BM; Schade, W; Werner, JA | 1 |
| Görögh, T; Lippert, BM; Rudert, H; Schade, W; Werner, JA | 1 |
| Hsu, CY; Jan, JS; Lin, JC; Wong, DY | 1 |
| Budach, W | 1 |
| Suba, Z; Szabó, G | 1 |
| Haase, S; Hemmer, J; Kreidler, J; Thein, T | 1 |
| Hemmer, J | 1 |
2 review(s) available for epirubicin and Mouth Neoplasms
| Article | Year |
|---|---|
Experimental studies on the phototoxic effect of cytostatic agents. Results and outlook.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Combined Modality Therapy; Doxorubicin; Epirubicin; Humans; Laser Therapy; Maximum Allowable Concentration; Mouth; Mouth Neoplasms; Photochemotherapy | 1995 |
[Histological evaluation of the effect of intra-arterial cytostatic treatment].
Topics: Antineoplastic Agents; Cisplatin; Epirubicin; Humans; Injections, Intra-Arterial; Mouth Mucosa; Mouth Neoplasms; Remission Induction | 1991 |
2 trial(s) available for epirubicin and Mouth Neoplasms
| Article | Year |
|---|---|
High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Patient Compliance; Prospective Studies; Treatment Outcome | 1999 |
[Intra-arterial preoperative chemotherapy versus preoperative radiotherapy].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Carotid Artery, External; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Epirubicin; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Mouth Floor; Mouth Neoplasms; Neoplasm Recurrence, Local; Odds Ratio; Osteoradionecrosis; Preoperative Care; Quality of Life; Radiotherapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Surveys and Questionnaires; Time Factors; Tongue Neoplasms | 2001 |
3 other study(ies) available for epirubicin and Mouth Neoplasms
| Article | Year |
|---|---|
[Anthracycline derivatives as photosensitizing agents in photodynamic laser therapy: an in vitro study with squamous epithelial cancer cells of the mouth cavity].
Topics: Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Survival; Doxorubicin; Epirubicin; Humans; Mouth Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1993 |
Monitoring of intra-arterial treatment with epirubicin and cisplatin in oral carcinoma by DNA flow cytometry.
Topics: Carcinoma, Squamous Cell; Cisplatin; DNA, Neoplasm; Epirubicin; Flow Cytometry; Humans; Infusions, Intra-Arterial; Mouth Neoplasms; Ploidies | 1991 |
Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carcinoma; Cell Cycle; Cisplatin; Colony-Forming Units Assay; DNA, Neoplasm; Epirubicin; Flow Cytometry; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Tumor Stem Cell Assay | 1990 |